Fundraising Fox

Cytovale

San Francisco, US · 6 known investors

cytovale.com ↗

Cytovale develops microfluidic deformability cytometry technology for immune response diagnostics, with a focus on early detection and diagnosis in hospital settings. The company serves healthcare systems and clinicians with diagnostic instruments and solutions.

BiotechDigital HealthHealthtechMedical Devicesin /cytovale

Founders & leadership

AS
Ajay ShahinCo-founder & CEO
HT
Henry TseinCo-founder & Chief Technology Officer
DD
Dino DiCarloDirector, Promoter
JF
Jack FuchsinDirector, Promoter
LF
Lindy FishburneDirector

Investors · 6

Breakout VenturesSan Francisco · $500K – $6M
Norwest Venture PartnersMenlo Park · $10M – $30M
Pathway BioventuresChicago
Breakout Labsreported
Breakout Ventures /DEreportedSan Francisco
Dolby Family VenturesreportedSan Francisco

Reported raises · per SEC filings

Form D private placements
$16.4MraisedJan 2022 · 23 investors · Biotechnology
Rule 506(b)
$7.4MraisedOct 2019 · 15 investors · Biotechnology
Rule 506(b)
$7.2MraisedDec 2017 · 7 investors · Other
Rule 506(b)

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news